Neoasia Indonesia Successfully Hosts the 3rd Neoasia Indonesia Scientific Symposium (NISS 2026)

Neoasia Indonesia proudly organised the 3rd Neoasia Indonesia Scientific Symposium (NISS 2026) on 19 April 2026 at Swissôtel PIK Jakarta, bringing together 300 doctors from across Indonesia for a landmark day of scientific exchange, clinical sharing, and collaboration.

NISS 2026 was a remarkable milestone event, reflecting Neoasia Indonesia’s continued commitment to advancing medical aesthetics through science‑driven education and innovation. The symposium featured a comprehensive scientific programme covering new clinical insights, evolving technologies, and practical applications across Neoasia’s growing portfolio, including Aknicare, Calecim, Heliocare, Neoretin, pbserum and Profhilo.

A major highlight of the symposium was the introduction and clinical discussion of upcoming launches in Indonesia this year — Calecim, Heliocare Oral and pbserum. These topics generated strong interest, showcasing Neoasia’s forward‑looking approach in expanding treatment possibilities across regenerative aesthetics, skin health, hair science, and photoprotection.

Throughout the day, speakers shared insights on acne management, pigmentation, photoprotection (including oral photoprotection), regenerative skin and hair science, bioremodelling, and adipose tissue restoration, offering attendees a balanced and holistic scientific perspective applicable to daily clinical practice.

The scientific agenda was delivered by an esteemed international and regional faculty:

– Prof Goh Chee Leok (Singapore)

– Dr M. Akbar Wedyadhana (Indonesia)

– Dr Irene Gaile Robredo Vitas (Philippines)

– Dr Martha (Indonesia)

– Dr Achmad Yudha Pranata (Indonesia)

– Dr Lam Bee Lan (Singapore)

– Dr Brenda Gamboa (Spain)

– Dr Mathelda Weni (Indonesia)

Each speaker contributed valuable clinical experience and scientific perspectives, creating an engaging and well‑rounded programme that encouraged discussion, critical thinking, and knowledge exchange among participants.

NISS 2026 was officially opened by Mr Chen Heng Hui, CEO of Neoasia Group, reaffirming Neoasia’s vision to build strong partnerships with the medical community and to continuously elevate standards of patient care through education.

With its diverse scientific topics, international collaboration, and milestone product introductions, NISS 2026 stands as a truly memorable and impactful event, reinforcing Neoasia Indonesia’s position as a key partner in the advancement of medical aesthetics in Indonesia.